Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported EBS revenue for 2025-12-31 was $742.9M. Net income was $52.6M. EBS currently screens at market cap $416.4M.
Use this EBS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the EBS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the EBS SEC filings page. Lician reads the product cache first so this HTML stays unique to Emergent Biosolutions Inc even when a live quote feed is slow.
Latest cached year on this hub. Full EBS income, balance, and cash tables.